automated-biomarker-discovery-from-omics-data, automated-feature-selection-with-bias-reduction, model-interpretability-and-explanation, collaborative-project-management-and-sharing, predictive-model-training-and-validation, visual-machine-learning-workflow-builder, dataset-quality-assessment-and-preprocessing, biomarker-performance-benchmarking, interactive-data-visualization-and-exploration, freemium-model-with-limited-data-testing, multi-omics-data-integration, clinical-outcome-prediction-modeling

JADBio

ProductFree

JADBio is a no-code machine learning tool that automates the discovery of biomarkers, making it ideal for researchers in drug discovery, biomarker...

Best for:Academic and pharma researchers seeking rapid biomarker validation without machine learning expertise, particularly those working with medium-to-large omics datasets.

/ 100

12 capabilities

Capabilities12 decomposed

automated-biomarker-discovery-from-omics-data

Medium confidence

Automatically identifies candidate biomarkers from high-dimensional omics datasets (genomics, proteomics, metabolomics) without requiring manual feature engineering or machine learning expertise. The system applies statistical and machine learning algorithms to rank and select the most predictive biological features.

Solves for

I need to find which genes or proteins predict treatment response in my patient cohortI want to identify disease-associated biomarkers from my omics dataset without hiring a data scientistI need to narrow down thousands of potential features to the most relevant ones for my study

Best for

wet-lab researchers without machine learning background

academic biomedical researchers

pharmaceutical drug discovery teams

Requires

structured omics dataset with samples and features

clinical outcome or phenotype labels for supervised learning

data in standard formats (CSV, Excel, or similar)

Limitations

Performance on small sample sizes (n<50) is not well-documented

Requires sufficient data quality and preprocessing before upload

Limited control over algorithm selection and hyperparameter tuning

automated-feature-selection-with-bias-reduction

Medium confidence

Systematically selects the most informative features from high-dimensional datasets while reducing researcher bias and preventing overfitting through automated cross-validation and statistical testing. Handles feature selection without manual intervention or subjective threshold setting.

Solves for

I want to reduce my 20,000 gene features down to a manageable set without introducing biasI need to validate that my selected features generalize to new dataI want to avoid the researcher bias that comes from manually cherry-picking features

Best for

researchers working with high-dimensional datasets

teams concerned about reproducibility and publication standards

studies with limited sample sizes where overfitting is a major risk

Requires

labeled dataset with outcome variable

sufficient samples relative to feature count

clean, preprocessed data

Limitations

Algorithm selection and rationale not fully transparent to users

May not capture complex feature interactions

Requires balanced or stratified datasets for optimal performance

model-interpretability-and-explanation

Medium confidence

Provides explanations for model predictions and biomarker selections, helping researchers understand which features drive predictions and how models make decisions.

Solves for

I want to understand why my model selected these specific biomarkersI need to explain my model's predictions to clinicians and stakeholdersI want to validate that my model is using biologically meaningful features

Best for

researchers preparing publications

teams developing clinical decision support tools

studies requiring regulatory approval

Requires

trained model

feature metadata and biological context

Limitations

Interpretability methods may be limited or generic

Complex models may still be difficult to explain

Biological validation of feature importance not automated

collaborative-project-management-and-sharing

Medium confidence

Enables researchers to organize analyses into projects, share results with collaborators, and maintain version history of analyses and datasets for team-based biomarker discovery research.

Solves for

I want to share my analysis with my research team membersI need to track changes to my analysis over timeI want to organize multiple related biomarker discovery projects

Best for

research teams and collaborations

institutions with multiple users

studies requiring audit trails for regulatory compliance

Requires

multiple user accounts

institutional or team subscription

Limitations

Collaboration features may be limited on free tier

Permission management may be basic

Version control may not be as sophisticated as code repositories

predictive-model-training-and-validation

Medium confidence

Automatically trains machine learning models on biomedical data and validates their performance using cross-validation techniques without requiring users to specify algorithms or tune hyperparameters. Handles model selection and evaluation end-to-end.

Solves for

I want to build a predictive model for patient outcomes from my biomarker dataI need to know how well my model will perform on new, unseen patientsI want to compare different model architectures without writing code

Best for

researchers building diagnostic or prognostic models

teams without machine learning expertise

studies requiring rapid model validation

Requires

labeled training dataset

sufficient sample size for meaningful cross-validation

balanced or properly weighted outcome classes

Limitations

Limited insight into which algorithms were selected or why

Hyperparameter choices not exposed to users for customization

Performance on imbalanced datasets not well-documented

visual-machine-learning-workflow-builder

Medium confidence

Provides an intuitive graphical interface for designing machine learning pipelines without writing code, allowing researchers to connect data inputs, preprocessing steps, feature selection, and model training through a visual canvas.

Solves for

I want to design a machine learning workflow without learning Python or RI need to document my analysis pipeline visually for my research teamI want to experiment with different pipeline configurations quickly

Best for

non-technical researchers

teams prioritizing ease-of-use over customization

researchers needing to document workflows for collaboration

Requires

basic understanding of machine learning concepts

web browser access

prepared input data

Limitations

Limited flexibility compared to code-based approaches

May not support advanced or custom preprocessing steps

Workflow complexity is constrained by UI design

dataset-quality-assessment-and-preprocessing

Medium confidence

Analyzes input datasets for quality issues, missing values, outliers, and data type inconsistencies, providing recommendations for preprocessing and data cleaning before model training.

Solves for

I want to understand the quality of my dataset before investing time in analysisI need to identify and handle missing values and outliers in my omics dataI want to ensure my data is properly formatted for machine learning

Best for

researchers new to machine learning

teams with heterogeneous data sources

studies requiring data quality documentation

Requires

raw or minimally processed dataset

metadata about data collection and handling

Limitations

Preprocessing recommendations may be generic rather than domain-specific

Limited ability to handle complex data quality issues

May not detect subtle batch effects or technical artifacts

biomarker-performance-benchmarking

Medium confidence

Evaluates and compares the predictive performance of identified biomarkers across multiple metrics (sensitivity, specificity, AUC, etc.) and provides statistical significance testing to validate biomarker utility.

Solves for

I want to know if my identified biomarkers are statistically significantI need to compare the performance of different biomarker combinationsI want to report biomarker performance metrics for publication

Best for

researchers preparing manuscripts

teams validating biomarker candidates

clinical researchers assessing diagnostic utility

Requires

biomarker predictions and actual outcomes

sufficient sample size for meaningful statistics

properly labeled validation data

Limitations

Statistical testing may not account for multiple comparisons correction

Limited support for specialized biomarker evaluation metrics

Performance estimates may be optimistic on small datasets

interactive-data-visualization-and-exploration

Medium confidence

Generates interactive visualizations of datasets, model results, and biomarker distributions, allowing researchers to explore patterns, relationships, and model predictions through charts, plots, and heatmaps.

Solves for

I want to visualize how my biomarkers separate disease from healthy samplesI need to explore relationships between features in my datasetI want to create publication-quality figures from my analysis results

Best for

researchers preparing presentations and manuscripts

teams exploring data patterns interactively

studies requiring visual validation of results

Requires

analysis results or raw data

web browser for interactive exploration

Limitations

Visualization options may be limited compared to specialized tools

Customization of plots may be restricted

Large datasets may have performance issues

freemium-model-with-limited-data-testing

Medium confidence

Offers a free tier allowing researchers to test the platform on real data with limited computational resources before committing to a paid subscription, reducing adoption barriers for academic institutions.

Solves for

I want to try this tool on my data before asking my institution to buy a licenseI need to evaluate whether this platform is suitable for my researchI want to test the tool without upfront financial commitment

Best for

academic researchers with limited budgets

teams evaluating multiple tools

institutions considering platform adoption

Requires

account creation

sample dataset for testing

Limitations

Free tier likely has computational limits or feature restrictions

May not support large-scale analyses on free plan

Limited support or priority on free tier

multi-omics-data-integration

Medium confidence

Integrates and analyzes data from multiple omics modalities (genomics, proteomics, metabolomics, etc.) simultaneously, identifying biomarkers that leverage information across different biological measurement types.

Solves for

I have gene expression and protein data and want to find biomarkers using bothI want to identify multi-omics signatures that predict treatment responseI need to integrate heterogeneous biological data types in a single analysis

Best for

researchers with multi-omics datasets

teams studying complex biological systems

studies seeking robust biomarkers across modalities

Requires

multiple omics datasets with aligned samples

proper normalization and preprocessing of each modality

sufficient sample overlap across data types

Limitations

Integration approach and algorithm selection not transparent

May struggle with highly imbalanced omics data

Requires careful data normalization across modalities

clinical-outcome-prediction-modeling

Medium confidence

Builds predictive models for clinical outcomes (treatment response, disease progression, patient survival) from biomarker and clinical data, enabling personalized medicine applications.

Solves for

I want to predict which patients will respond to a specific drug treatmentI need to build a model that predicts disease progression in my patient cohortI want to develop a tool for personalized treatment selection

Best for

pharmaceutical researchers in drug development

clinical researchers studying treatment response

teams developing companion diagnostics

Requires

biomarker measurements and clinical data

clearly defined clinical outcomes

adequate follow-up time and outcome documentation

Limitations

Model interpretability may be limited for regulatory submissions

Requires well-defined clinical outcomes and follow-up data

Performance on rare outcomes or small subgroups not well-documented

Capabilities are decomposed by AI analysis. Each maps to specific user intents and improves with match feedback.

Related Artifactssharing capabilities

Artifacts that share capabilities with JADBio, ranked by overlap. Discovered automatically through the match graph.

Product27

MindsDB

NLP inside your...

explainability and model interpretationautomated model selection and hyperparameter tuningautomated feature engineering

3 shared capabilities

Product27

Qlik AutoML

No-code machine learning for accessible, powerful predictive...

automated-model-selectionautomated-feature-engineeringmodel-explainability-reporting

3 shared capabilities

Platform40

Azure Machine Learning

Microsoft's enterprise ML platform with AutoML and responsible AI dashboards.

responsible ai dashboard with fairness metrics and model interpretabilityautomated machine learning model generation across multiple problem types

2 shared capabilities

Product31

Liner.ai

Unlock machine learning: code-free, end-to-end, fast, and accessible to...

model selection and comparison from pre-trained libraryperformance visualization and model interpretation

2 shared capabilities

Product27

Helicon

Optimize AI deployment, observability, and explainability...

model explainability and interpretability

1 shared capability

Product27

Holistic AI

Empower AI adoption with comprehensive governance, risk management, and...

model-explainability-and-interpretability

1 shared capability

Best For

✓wet-lab researchers without machine learning background
✓academic biomedical researchers
✓pharmaceutical drug discovery teams
✓clinical researchers validating biomarkers
✓researchers working with high-dimensional datasets
✓teams concerned about reproducibility and publication standards
✓studies with limited sample sizes where overfitting is a major risk
✓researchers preparing publications

Known Limitations

⚠Performance on small sample sizes (n<50) is not well-documented
⚠Requires sufficient data quality and preprocessing before upload
⚠Limited control over algorithm selection and hyperparameter tuning
⚠Algorithm selection and rationale not fully transparent to users
⚠May not capture complex feature interactions
⚠Requires balanced or stratified datasets for optimal performance

Requirements

structured omics dataset with samples and featuresclinical outcome or phenotype labels for supervised learningdata in standard formats (CSV, Excel, or similar)labeled dataset with outcome variablesufficient samples relative to feature countclean, preprocessed datatrained modelfeature metadata and biological context

Input / Output

Accepts: tabular data (CSV, Excel), omics datasets (gene expression, protein abundance, metabolite levels), clinical phenotype labels, tabular data with features and labels, high-dimensional datasets (hundreds to thousands of features), trained predictive models, feature importance data, analysis projects, datasets, results, tabular biomedical data, clinical outcome labels, feature matrices, data files, configuration parameters, tabular data files, omics datasets, predicted values from biomarker models, ground truth outcome labels, biomarker expression or abundance values, dataset features and outcomes, model predictions, biomarker expression values, biomedical datasets, gene expression data, protein abundance data, metabolite measurements, other omics modalities, biomarker data, clinical variables, outcome labels (response/non-response, survival time, etc.)

Produces: ranked list of biomarker candidates, feature importance scores, predictive model performance metrics, subset of selected features, feature ranking/importance scores, cross-validation performance estimates, feature importance rankings, prediction explanations, interpretability visualizations, biological context annotations, shared project access, version history, collaboration notifications, audit logs, trained predictive model, performance metrics (accuracy, AUC, sensitivity, specificity), cross-validation results, model predictions on test data, visual workflow diagram, executable pipeline, analysis results, data quality report, preprocessing recommendations, cleaned dataset, quality metrics and visualizations, performance metrics (sensitivity, specificity, AUC, PPV, NPV), ROC curves and other performance visualizations, statistical significance tests, comparison tables, interactive plots and charts, heatmaps and correlation matrices, ROC curves and performance plots, exportable visualizations (PNG, PDF), analysis results on free tier, performance demonstration, integrated biomarker signatures, multi-omics feature rankings, cross-modality correlation analysis, predictive model, patient risk scores, outcome probability predictions, model performance metrics

UnfragileRank

Adoption15%(30% weight)

Quality59%(25% weight)

Ecosystem25%(15% weight)

Match Graph10%(25% weight)

Freshness100%(5% weight)

UnfragileRank is computed from adoption signals, documentation quality, ecosystem connectivity, match graph feedback, and freshness. No artifact can pay for a higher rank.

Type: Product

12 capabilities

Visit JADBio→

About

JADBio is a no-code machine learning tool that automates the discovery of biomarkers, making it ideal for researchers in drug discovery, biomarker identification, and response to treatment studies

Unfragile Review

JADBio democratizes machine learning for biomedical researchers by eliminating the need for coding expertise, allowing scientists to rapidly identify biomarkers from complex datasets through an intuitive visual interface. The platform's automated feature selection and model validation processes significantly accelerate drug discovery workflows, though its effectiveness is heavily dependent on data quality and size.

Pros

+No-code interface makes advanced ML accessible to wet-lab researchers without programming skills, eliminating the typical data science bottleneck in biomarker discovery
+Automated feature selection and cross-validation reduce researcher bias and prevent overfitting on small biomedical datasets
+Freemium model allows researchers to test on real data before institutional investment, lowering barriers to adoption

Cons

-Limited transparency into algorithm selection and hyperparameter tuning decisions may concern researchers requiring full methodological control for publication
-Performance on small sample sizes (common in early-stage biomarker studies) is not well-documented, raising questions about reliability in resource-constrained research settings

Alternatives to JADBio

TrendRadar51MCP Server

⭐AI-driven public opinion & trend monitor with multi-platform aggregation, RSS, and smart alerts.🎯 告别信息过载，你的 AI 舆情监控助手与热点筛选工具！聚合多平台热点 + RSS 订阅，支持关键词精准筛选。AI 智能筛选新闻 + AI 翻译 + AI 分析简报直推手机，也支持接入 MCP 架构，赋能 AI 自然语言对话分析、情感洞察与趋势预测等。支持 Docker ，数据本地/云端自持。集成微信/飞书/钉钉/Telegram/邮件/ntfy/bark/slack 等渠道智能推送。

Compare →

TaskWeaver50Agent

The first "code-first" agent framework for seamlessly planning and executing data analytics tasks.

Compare →

Power Query32Product

Transform data seamlessly with intuitive ETL...

Compare →

Abridge29Product

Revolutionizes healthcare documentation, saving time, enhancing care, Epic-integrated...

Compare →

Are you the builder of JADBio?

Claim this artifact to get a verified badge, access match analytics, see which intents users search for, and manage your listing.

Claim this artifact →Verification via email

Get the weekly brief

New tools, rising stars, and what's actually worth your time. No spam.

Data Sources

github awesome

Looking for something else?

Search →

Capabilities12 decomposed

automated-biomarker-discovery-from-omics-data

Medium confidence

Solves for

Best for

wet-lab researchers without machine learning background

academic biomedical researchers

pharmaceutical drug discovery teams

Requires

structured omics dataset with samples and features

clinical outcome or phenotype labels for supervised learning

data in standard formats (CSV, Excel, or similar)

Limitations

Performance on small sample sizes (n<50) is not well-documented

Requires sufficient data quality and preprocessing before upload

Limited control over algorithm selection and hyperparameter tuning

automated-feature-selection-with-bias-reduction

Medium confidence

Solves for

Best for

researchers working with high-dimensional datasets

teams concerned about reproducibility and publication standards

studies with limited sample sizes where overfitting is a major risk

Requires

labeled dataset with outcome variable

sufficient samples relative to feature count

clean, preprocessed data

Limitations

Algorithm selection and rationale not fully transparent to users

May not capture complex feature interactions

Requires balanced or stratified datasets for optimal performance

model-interpretability-and-explanation

Medium confidence

Provides explanations for model predictions and biomarker selections, helping researchers understand which features drive predictions and how models make decisions.

Solves for

Best for

researchers preparing publications

teams developing clinical decision support tools

studies requiring regulatory approval

Requires

trained model

feature metadata and biological context

Limitations

Interpretability methods may be limited or generic

Complex models may still be difficult to explain

Biological validation of feature importance not automated

collaborative-project-management-and-sharing

Medium confidence

Enables researchers to organize analyses into projects, share results with collaborators, and maintain version history of analyses and datasets for team-based biomarker discovery research.

Solves for

I want to share my analysis with my research team membersI need to track changes to my analysis over timeI want to organize multiple related biomarker discovery projects

Best for

research teams and collaborations

institutions with multiple users

studies requiring audit trails for regulatory compliance

Requires

multiple user accounts

institutional or team subscription

Limitations

Collaboration features may be limited on free tier

Permission management may be basic

Version control may not be as sophisticated as code repositories

predictive-model-training-and-validation

Medium confidence

Solves for

Best for

researchers building diagnostic or prognostic models

teams without machine learning expertise

studies requiring rapid model validation

Requires

labeled training dataset

sufficient sample size for meaningful cross-validation

balanced or properly weighted outcome classes

Limitations

Limited insight into which algorithms were selected or why

Hyperparameter choices not exposed to users for customization

Performance on imbalanced datasets not well-documented

visual-machine-learning-workflow-builder

Medium confidence

Solves for

Best for

non-technical researchers

teams prioritizing ease-of-use over customization

researchers needing to document workflows for collaboration

Requires

basic understanding of machine learning concepts

web browser access

prepared input data

Limitations

Limited flexibility compared to code-based approaches

May not support advanced or custom preprocessing steps

Workflow complexity is constrained by UI design

dataset-quality-assessment-and-preprocessing

Medium confidence

Analyzes input datasets for quality issues, missing values, outliers, and data type inconsistencies, providing recommendations for preprocessing and data cleaning before model training.

Solves for

Best for

researchers new to machine learning

teams with heterogeneous data sources

studies requiring data quality documentation

Requires

raw or minimally processed dataset

metadata about data collection and handling

Limitations

Preprocessing recommendations may be generic rather than domain-specific

Limited ability to handle complex data quality issues

May not detect subtle batch effects or technical artifacts

biomarker-performance-benchmarking

Medium confidence

Solves for

Best for

researchers preparing manuscripts

teams validating biomarker candidates

clinical researchers assessing diagnostic utility

Requires

biomarker predictions and actual outcomes

sufficient sample size for meaningful statistics

properly labeled validation data

Limitations

Statistical testing may not account for multiple comparisons correction

Limited support for specialized biomarker evaluation metrics

Performance estimates may be optimistic on small datasets

interactive-data-visualization-and-exploration

Medium confidence

Solves for

Best for

researchers preparing presentations and manuscripts

teams exploring data patterns interactively

studies requiring visual validation of results

Requires

analysis results or raw data

web browser for interactive exploration

Limitations

Visualization options may be limited compared to specialized tools

Customization of plots may be restricted

Large datasets may have performance issues

freemium-model-with-limited-data-testing

Medium confidence

Solves for

Best for

academic researchers with limited budgets

teams evaluating multiple tools

institutions considering platform adoption

Requires

account creation

sample dataset for testing

Limitations

Free tier likely has computational limits or feature restrictions

May not support large-scale analyses on free plan

Limited support or priority on free tier

multi-omics-data-integration

Medium confidence

Solves for

Best for

researchers with multi-omics datasets

teams studying complex biological systems

studies seeking robust biomarkers across modalities

Requires

multiple omics datasets with aligned samples

proper normalization and preprocessing of each modality

sufficient sample overlap across data types

Limitations

Integration approach and algorithm selection not transparent

May struggle with highly imbalanced omics data

Requires careful data normalization across modalities

clinical-outcome-prediction-modeling

Medium confidence

Builds predictive models for clinical outcomes (treatment response, disease progression, patient survival) from biomarker and clinical data, enabling personalized medicine applications.

Solves for

Best for

pharmaceutical researchers in drug development

clinical researchers studying treatment response

teams developing companion diagnostics

Requires

biomarker measurements and clinical data

clearly defined clinical outcomes

adequate follow-up time and outcome documentation

Limitations

Model interpretability may be limited for regulatory submissions

Requires well-defined clinical outcomes and follow-up data

Performance on rare outcomes or small subgroups not well-documented

Capabilities are decomposed by AI analysis. Each maps to specific user intents and improves with match feedback.

Unfragile Review

Alternatives to JADBio

TrendRadar51MCP Server

Compare →

TaskWeaver50Agent

The first "code-first" agent framework for seamlessly planning and executing data analytics tasks.

Compare →

Power Query32Product

Transform data seamlessly with intuitive ETL...

Compare →

Abridge29Product

Revolutionizes healthcare documentation, saving time, enhancing care, Epic-integrated...

Compare →

JADBio

Capabilities12 decomposed

automated-biomarker-discovery-from-omics-data

automated-feature-selection-with-bias-reduction

model-interpretability-and-explanation

collaborative-project-management-and-sharing

predictive-model-training-and-validation

visual-machine-learning-workflow-builder

dataset-quality-assessment-and-preprocessing

biomarker-performance-benchmarking

interactive-data-visualization-and-exploration

freemium-model-with-limited-data-testing

multi-omics-data-integration

clinical-outcome-prediction-modeling

Related Artifactssharing capabilities

MindsDB

Qlik AutoML

Azure Machine Learning

Liner.ai

Helicon

Holistic AI

Best For

Known Limitations

Requirements

Input / Output

UnfragileRank

About

Unfragile Review

Pros

Cons

Categories

Alternatives to JADBio

Are you the builder of JADBio?

Get the weekly brief

Data Sources

JADBio

Capabilities12 decomposed

automated-biomarker-discovery-from-omics-data

automated-feature-selection-with-bias-reduction

model-interpretability-and-explanation

collaborative-project-management-and-sharing

predictive-model-training-and-validation

visual-machine-learning-workflow-builder

dataset-quality-assessment-and-preprocessing

biomarker-performance-benchmarking

interactive-data-visualization-and-exploration

freemium-model-with-limited-data-testing

multi-omics-data-integration

clinical-outcome-prediction-modeling

Related Artifactssharing capabilities

MindsDB

Qlik AutoML

Azure Machine Learning

Liner.ai

Helicon

Holistic AI

Best For

Known Limitations

Requirements

Input / Output

UnfragileRank

About

Unfragile Review

Pros

Cons

Categories

Alternatives to JADBio

Are you the builder of JADBio?

Get the weekly brief

Data Sources